AnRes Clinical ApS
AnRes Clinical ApS is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and immune response of single and multiple ascending doses of TOL2 (Immune Tolerising Agent) in patients with generalised myasthenia gravis
Sponsor Bonsai Biotherapeutics AB
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with Riluzole versus placebo in combination with Riluzole in the treatment of patients suffering from Amyotrophic Lateral Sclerosis (ALS)
Sponsor Ab Science
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for AnRes Clinical ApS?
The 2026-10-09 snapshot links AnRes Clinical ApS to 2 distinct CTIS trials. Recorded services include Clinical monitoring, Project management, Regulatory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for AnRes Clinical ApS?
The most frequently recorded therapeutic areas are Immunology, Neurology. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to AnRes Clinical ApS conducted?
The linked trials record locations in 6 countries, including Denmark, Sweden, Germany, France, Greece. These are trial locations, not confirmed office locations or countries where AnRes Clinical ApS delivered services.
What can this page tell me about AnRes Clinical ApS's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under AnRes Clinical ApS. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- AnRes Clinical ApS